Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MRNA · against 1,372 other Healthcare companies
Ranked #759 of 1,373 · scores higher than 45% of peers · safety percentile 45
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 40–49, including MRNA · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MRNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.19× | 0.24× | 55% | 33% | |
| BetaLower is better · 1,320 reported | 1.09 | 0.53 | 21% | 33% | |
| Current ratioHigher is better · 1,338 reported | 2.29× | 2.62× | 46% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 755 | Unavailable | 45 | 56 | |
| 756 | 13.8B CNY (≈$1.9B) | 45 | 51 | |
| 757 | 5.3B CNY (≈$738M) | 45 | 40 | |
| 758 | 406.2B KRW (≈$292M) | 45 | 51 | |
| 759 | 91.2B USD | 45 | 18 | |
| 760 | 1.1B MYR (≈$245M) | 45 | 70 | |
| 761 | 22.3B SGD (≈$16.9B) | 45 | 57 | |
| 762 | 4.6B SEK (≈$462M) | 45 | 37 | |
| 763 | 4.0B CNY (≈$563M) | 44 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score